Filing Flows › Orthopediatrics (KIDS) › Q3 2025
Orthopediatrics (KIDS) Q3 2025 earnings results (third quarter 2025)
10-Q filed Oct 29, 2025
Orthopediatrics (KIDS) reported revenue of $61.2M for the third quarter 2025 (Q3 2025), +12% from a year earlier and +0.3% from the quarter before. Operating margin was -15.4%, net loss $11.8M (19.2% of revenue).
Orthopediatrics, Q3 2025: revenue $61.2M (+12% year over year), operating margin -15.4%, net loss $11.8M, operating cash flow −$581K. The chart follows the revenue to costs, profit and cash.
| Q3 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $61.2M | +0.3% | +12% |
| Operating profit | −$9.4M | — | — |
| Net earnings | −$11.8M | — | — |
| Operating cash flow | −$581K | — | — |
What changed
Revenue was $61.2M in Q3 2025, up 12% year over year and roughly flat from the previous quarter. Trauma and deformity was the largest line at 72% of revenue. Trauma and deformity added $6.5M year over year (up 17%), 97% of the total change. Sports medicine/other declined 35%.
Gross margin was 73.9%, up 0.5 points from a year earlier. Operating costs exceeded revenue by $9.4M, an operating margin of -15.4%. Operating expenses grew 20% against revenue growth of 12%. The fastest-growing cost line was Sales & marketing (+11%). The quarter ended with a net loss of $11.8M, wider than the previous quarter's $7.1M loss.
Operating cash flow was −$581K. Non-cash charges added back $5.3M of depreciation and amortization and $4.3M of share-based compensation. Working capital and other items added $1.6M. Capital expenditures of $2.8M exceeded it, leaving free cash flow of −$3.4M.
Questions
What was Orthopediatrics' revenue in the third quarter 2025?
Orthopediatrics (KIDS) reported revenue of $61.2M for the third quarter 2025 (Q3 2025), +12% from a year earlier and +0.3% from the quarter before.
Was Orthopediatrics profitable in the third quarter 2025?
Operating loss was $9.4M (-15.4% of revenue) and net loss $11.8M.
Source: Orthopediatrics 10-Q on SEC EDGAR.